ZHIQIANG XIA
Broker in Acton, MA
License number
Massachusetts 9506735
Issued Date
Jan 5, 2008
Expiration Date
Nov 5, 2010
Type
Salesperson
Address
Address
Acton, MA 01720
Professional information
Zhiqiang Xia - Acton, MA
Work:
Synta Pharmaceuticals
Principal Scientist Synta Pharmaceuticals
Senior Scientist Synta Pharmaceuticals
Scientist Institute of Biological Chemistry, Washington State University - Pullman, WA
Research Scientist Department of Chemistry, University of Oulu, Finland
Visiting Scientist Institute fr Pharmazeutische Biologie, Technishe Universitt, Brauschweig, Germany
Visiting Scientist Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China
Assistant Professor
Principal Scientist Synta Pharmaceuticals
Senior Scientist Synta Pharmaceuticals
Scientist Institute of Biological Chemistry, Washington State University - Pullman, WA
Research Scientist Department of Chemistry, University of Oulu, Finland
Visiting Scientist Institute fr Pharmazeutische Biologie, Technishe Universitt, Brauschweig, Germany
Visiting Scientist Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China
Assistant Professor
Education:
Universitt Mchen
Humboldt Fellowship Chinese Academy of Sciences
Ph.D. in Organic Chemistry Wuhan University
B.Sc. in Organic Chemistry
Humboldt Fellowship Chinese Academy of Sciences
Ph.D. in Organic Chemistry Wuhan University
B.Sc. in Organic Chemistry
Compounds For Inflammation And Immune-Related Uses
US Patent:
2014003, Feb 6, 2014
Filed:
Oct 15, 2013
Appl. No.:
14/053896
Inventors:
Shoujun Chen - Bedford MA, US
Zhiqiang Xia - Acton MA, US
Jun Jiang - Norwood MA, US
Yu Xie - Natick MA, US
Junyi Zhang - Lexington MA, US
Zhiqiang Xia - Acton MA, US
Jun Jiang - Norwood MA, US
Yu Xie - Natick MA, US
Junyi Zhang - Lexington MA, US
Assignee:
Synta Pharmaceuticals Corp. - Lexington MA
International Classification:
C07D 413/12, A61K 31/24, A61K 45/06, C07D 263/32, A61K 31/421, C07D 213/81, A61K 31/44, C07D 257/04, A61K 31/41, A61K 31/4439, C07D 277/28, A61K 31/426, C07D 417/12, A61K 31/444, A61K 31/433, C07C 233/81
US Classification:
514335, 560 47, 514535, 514537, 548236, 514374, 546323, 514354, 548253, 514381, 5462714, 514340, 548202, 514365, 5462697, 514342, 546261, 5462687, 548127, 514361, 5462721
Abstract:
The invention relates to compounds of structural formulas (I), (VII) and (XI):or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein X, X, X, Y, Z, L, R, R, R, Rand n are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.
Compounds Inclunding Substituted Pyridines For Inflammation And Immune-Related Uses
US Patent:
8314130, Nov 20, 2012
Filed:
Oct 1, 2009
Appl. No.:
12/572103
Inventors:
Shoujun Chen - Bedford MA, US
Junyi Zhang - Lexington MA, US
Jun Jiang - Norwood MA, US
Gary Bohnert - Wilmington MA, US
Nha Vo - Southborough MA, US
Qinglin Che - Foxboro MA, US
Zhiqiang Xia - Acton MA, US
Lijun Sun - Harvard MA, US
Junyi Zhang - Lexington MA, US
Jun Jiang - Norwood MA, US
Gary Bohnert - Wilmington MA, US
Nha Vo - Southborough MA, US
Qinglin Che - Foxboro MA, US
Zhiqiang Xia - Acton MA, US
Lijun Sun - Harvard MA, US
Assignee:
Synta Pharmaceuticals Corp. - Lexington MA
International Classification:
A61K 31/44
US Classification:
514352, 544405, 546304, 548202, 548247, 5483731, 549 68
Abstract:
The invention relates to certain compounds including substituted pyridines, or pharmaceutically acceptable salts, solvates, clathrates, or prodrugs thereof, that are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.
Substituted Pyrazinamide Compounds For Inflammation And Immune-Related Uses
US Patent:
2013030, Nov 14, 2013
Filed:
Jul 3, 2013
Appl. No.:
13/935206
Inventors:
Zhiqiang Xia - Acton MA, US
Shoujun Chen - Bedford MA, US
Lijun Sun - Harvard MA, US
Shoujun Chen - Bedford MA, US
Lijun Sun - Harvard MA, US
International Classification:
C07D 401/04, A61K 45/06, A61K 31/497, C07D 401/14, C07D 417/14
US Classification:
51425211, 544405, 544357, 51425505
Abstract:
The invention relates to certain compounds, or pharmaceutically acceptable salts, solvates, clathrates, or prodrugs thereof, that are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.
Compounds For Inflammation And Immune-Related Uses
US Patent:
2012028, Nov 8, 2012
Filed:
Jul 19, 2012
Appl. No.:
13/552755
Inventors:
Shoujun Chen - Bedford MA, US
Junyi Zhang - Lexington MA, US
Jun Jiang - Norwood MA, US
Gary Bohnert - Wilmington MA, US
Nha Vo - Southborough MA, US
Qinglin Che - Foxboro MA, US
Zhiqiang Xia - Acton MA, US
Lijun Sun - Harvard MA, US
Junyi Zhang - Lexington MA, US
Jun Jiang - Norwood MA, US
Gary Bohnert - Wilmington MA, US
Nha Vo - Southborough MA, US
Qinglin Che - Foxboro MA, US
Zhiqiang Xia - Acton MA, US
Lijun Sun - Harvard MA, US
Assignee:
Synta Pharmaceuticals Corp. - Lexington MA
International Classification:
A61K 31/444, C07D 417/04, A61K 31/497, A61K 31/4436, C07D 409/06, C07D 409/14, C07D 417/14, A61K 31/4439
US Classification:
51425505, 546256, 514333, 5462704, 514342, 514341, 514336, 5462804, 544405
Abstract:
The invention relates to certain compounds, or pharmaceutically acceptable salts, solvates, clathrates, or prodrugs thereof, that are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.
Compounds For Inflammation And Immune-Related Uses
US Patent:
2012018, Jul 19, 2012
Filed:
Jan 17, 2012
Appl. No.:
13/351351
Inventors:
Gary Bohnert - Wilmington MA, US
Zhiqiang Xia - Acton MA, US
Shoujun Chen - Bedford MA, US
Lijun Sun - Harvard MA, US
Zhiqiang Xia - Acton MA, US
Shoujun Chen - Bedford MA, US
Lijun Sun - Harvard MA, US
Assignee:
Synta Pharmaceuticals Corp. - Lexington MA
International Classification:
A61K 45/00, A61K 31/56, A61K 31/497, A61K 31/444, A61K 31/4439, A61K 31/4418, A61K 31/44, C07D 417/14, C07D 401/14, C07D 401/04, C07D 417/04, C07D 211/98, C07D 211/96, A61P 37/06, A61P 29/00, A61P 37/08, A61P 25/00, A61P 7/06, A61P 19/02, A61P 17/06, A61P 1/00, A61P 3/10, A61P 19/08, A61P 11/00, A61P 11/06, A61P 31/14, A61P 25/28, A61P 9/10, A61P 15/00, A61P 1/16, A61P 35/00, A61P 25/16, C12N 5/02
US Classification:
4242781, 435375, 514171, 51425211, 51425505, 514334, 514340, 514342, 514354, 514357, 544357, 544405, 546256, 5462684, 5462704, 546326, 546329
Abstract:
The invention relates to certain compounds, or pharmaceutically acceptable salts, solvates, clathrates, or prodrugs thereof, that are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.
Compounds For Inflammation And Immune-Related Uses
US Patent:
2010012, May 20, 2010
Filed:
Oct 1, 2009
Appl. No.:
12/572079
Inventors:
Gary Bohnert - Wilmington MA, US
Zhiqiang Xia - Acton MA, US
Shoujun Chen - Bedford MA, US
Lijun Sun - Harvard MA, US
Zhiqiang Xia - Acton MA, US
Shoujun Chen - Bedford MA, US
Lijun Sun - Harvard MA, US
International Classification:
C07D 401/04, A61K 31/497, A61K 31/4436, C07D 417/04, C12N 5/00, A61P 29/00, A61P 37/00, A61P 19/02, A61P 17/00, A61P 37/08
US Classification:
51425505, 544405, 514342, 5462704, 435375
Abstract:
The invention relates to certain compounds, or pharmaceutically acceptable salts, solvates, clathrates, or prodrugs thereof, that are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.
Compounds For Inflammation And Immune-Related Uses
US Patent:
8524756, Sep 3, 2013
Filed:
Oct 16, 2012
Appl. No.:
13/652878
Inventors:
Jun Jiang - Norwood MA, US
Hao Li - Brookline MA, US
David A. James - Cambridge MA, US
Dinesh Chimmanamada - Waltham MA, US
Christopher Borella - Cambridge MA, US
Lijun Sun - Harvard MA, US
Yu Xie - Natick MA, US
Mats Holmqvist - Malden MA, US
Jerome Mahiou - Lexington MA, US
Zhiqiang Xia - Acton MA, US
Hao Li - Brookline MA, US
David A. James - Cambridge MA, US
Dinesh Chimmanamada - Waltham MA, US
Christopher Borella - Cambridge MA, US
Lijun Sun - Harvard MA, US
Yu Xie - Natick MA, US
Mats Holmqvist - Malden MA, US
Jerome Mahiou - Lexington MA, US
Zhiqiang Xia - Acton MA, US
Assignee:
Synta Pharmaceuticals Corp. - Lexington MA
International Classification:
A01N 43/52, A61K 31/415
US Classification:
514393
Abstract:
The invention relates to compounds of formula (I):.
Compounds For Inflammation And Immune-Related Uses
US Patent:
8314134, Nov 20, 2012
Filed:
Mar 5, 2010
Appl. No.:
12/718366
Inventors:
Shoujun Chen - Bedford MA, US
Jun Jiang - Acton MA, US
Hao Li - Brookline MA, US
David James - Cambridge MA, US
Dinesh Chimmanamada - Waltham MA, US
Christopher Borella - Cambridge MA, US
Lijun Sun - Harvard MA, US
Yu Xie - Natick MA, US
Mats Holmqvist - Malden MA, US
Jerome Mahiou - Lexington MA, US
Zhiqiang Xia - Acton MA, US
Jun Jiang - Acton MA, US
Hao Li - Brookline MA, US
David James - Cambridge MA, US
Dinesh Chimmanamada - Waltham MA, US
Christopher Borella - Cambridge MA, US
Lijun Sun - Harvard MA, US
Yu Xie - Natick MA, US
Mats Holmqvist - Malden MA, US
Jerome Mahiou - Lexington MA, US
Zhiqiang Xia - Acton MA, US
Assignee:
Synta Pharmaceuticals Corp. - Lexington MA
International Classification:
C07D 235/00, A01N 43/52, A61K 31/415
US Classification:
514393, 514394, 5483044, 5483107
Abstract:
The invention relates to compounds of formula (I):.
Fused Pyrrole Compounds
US Patent:
2005001, Jan 20, 2005
Filed:
Mar 12, 2004
Appl. No.:
10/799389
Inventors:
Mitsunori Ono - Lexington MA, US
Lijun Sun - Harvard MA, US
ZhiQiang Xia - Acton MA, US
Elena Kostik - Arlington MA, US
Keizo Koya - Chestnut Hill MA, US
Masazumi Nagai - Lexington MA, US
Yaming Wu - Lexington MA, US
Lijun Sun - Harvard MA, US
ZhiQiang Xia - Acton MA, US
Elena Kostik - Arlington MA, US
Keizo Koya - Chestnut Hill MA, US
Masazumi Nagai - Lexington MA, US
Yaming Wu - Lexington MA, US
International Classification:
C07D455/02, C07D487/04, A61K031/53, A61K031/519
US Classification:
514243000, 544183000, 544281000, 546138000, 514259100, 514306000
Abstract:
This invention relates to fused pyrrole compounds of Formula (I):